Oxymetazoline

Overview

Oxymetazoline is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL762).

API suppliers (2)

Suppliers of Oxymetazoline backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CTX LIFE SCIENCES PVT LTD1 active DMF
• LUSOCHIMICA SPAItaly

Patent & exclusivity (US)

Per the FDA Orange Book (4 approved US products), the latest listed US patent on Oxymetazoline expires 16 Dec 2039. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol

Canonical SMILES

CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C

InChIKey

WYWIFABBXFUGLM-UHFFFAOYSA-N